We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Update: 25 Human Drugs at Risk of Brexit Supply Disruptions
EMA Update: 25 Human Drugs at Risk of Brexit Supply Disruptions
The EMA lowered its estimate for the number of centrally authorized drugs that may face post-Brexit supply disruptions from 108 to 39 — including 25 human medicines.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor